InsidersTradesSigma
Explore the complete record of transactions filed by Markels John, Director. Insider active across 1 company, notably Sangamo Therapeutics, INC. Cumulatively, 2 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. History available since 25 February 2022. The latest transaction was filed on 3 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Markels John is a Board Member at SANGAMO THERAPEUTICS, INC. He provides strategic expertise to the board, contributing to the direction and governance of the company. His role is essential in developing policies that support sustainable growth.